Agonist anti-trkc antibodies and methods using same

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A61K 39/395 (2006.01) C12N 15/13 (2006.01)

Patent

CA 2551097

The invention concerns agonist anti-trkC antibodies, polypeptides, and polynucleotides encoding the same. The invention further concerns use of such antibodies, polypeptides and/or polynucleotides in the treatment and/or prevention of neuropathies, such as sensory neuropathies, including taxol- induced sensory neuropathy, cisplatin-induced sensory neuropathy, and pyridoxine-induced sensory neuropathy.

La présente invention concerne des anticorps anti-trkC agonistes, des polypeptides, et des polynucléotides codant pour ceux-ci. L'invention a également pour objet l'utilisation de ces anticorps, polypeptides et/ou polynucléotides dans le cadre du traitement et/ou de la prévention de neuropathies, telles que des neuropathies sensorielles, comprenant la neuropathie sensorielle induite par taxol, la neuropathie sensorielle induite par cisplatine, et la neuropathie sensorielle induite par pyridoxine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Agonist anti-trkc antibodies and methods using same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agonist anti-trkc antibodies and methods using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agonist anti-trkc antibodies and methods using same will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2016567

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.